Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders (eBook)

Artikelnummer: 978-3-030-05542-4
Einband: PDF
Verfügbarkeit: Download, sofort verfügbar (Link per E-Mail)
CHF 177.00
decrease increase

This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.


This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.


Schreiben Sie Ihre eigene Bewertung
  • Nur registrierte Benutzer können Produkte bewerten
*
*
Schlecht
Sehr gut
*
*
*
*
VerlagSpringer Nature Switzerland
EinbandPDF
Erscheinungsjahr2019
Seitenangabe328 S.
AusgabekennzeichenEnglisch
AbbildungenXIII, 328 p. 28 illus., 26 illus. in color.
Masse7'520 KB
PlattformPDF
ReiheProteomics, Metabolomics, Interactomics and Systems Biology; Advances in Experimental Medicine and Biology; Biomedical and Life Sciences; Biomedical and Life Sciences
AutorGuest, Paul C. (Hrsg.)

Alle Bände der Reihe "Proteomics, Metabolomics, Interactomics and Systems Biology; Advances in Experimental Medicine and Biology; Biomedical and Life Sciences; Biomedical and Life Sciences (R0)"

Über den Autor Paul C. (Hrsg.) Guest

Dr. Paul C. Guest, Ph.D, is a scientific researcher/writer with 38 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He is also affiliated with the University of Campinas in Sao Paulo Brazil and Otto-von-Guericke-University in Magdeburg Germany, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia, age-related diseases such as diabetes, cancer, cardiovascular disorders, sarcopenia and Alzheimer's disease, and more recently on infectious diseases such as COVID-19. 

Weitere Titel von Paul C. (Hrsg.) Guest

Produktbewertungen
Nur registrierte Benutzer können Produkte bewerten